A comprehensive view of Genmab A/S. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Genmab reports Q1 global net sales of injectable Darzalex at US$1.9B, with net US sales at US$953M, net sales in other parts of the world at US$903M; drug is first FDA-approved monoclonal antibody to treat multiple myeloma
Published: April 25, 2022 by Contify Life Science News
AbbVie, Genmab announce topline results from Phase1/2 trial of injectable Epcoritamab DuoBody-CD3xCD20 subcutaneous bispecific antibody in relapsed/refractory large B-cell lymphoma patients; every year about 150,000 new cases of LBCL reported worldwide
Published: April 14, 2022 by AbbVie Inc.

Ask us about our R&D/Patents market view

Trending Chart

Interactive chart with headline count